USD 0.01
(0.0%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | -1.37 Million | -1.23 Million | -789.27 Thousand | -672.5 Thousand | -503.68 Thousand | -760.13 Thousand |
Net Income | -3.26 Million | -2.42 Million | -1.95 Million | -1.04 Million | -887.42 Thousand | -769.61 Thousand |
Depreciation & Amortization | 1.67 Million | 2109.16 | 1147.58 | - | 78.54 | 135.77 |
Deferred income taxes | - | -2338.66 | -1573.83 | - | -268.68 | - |
Stock-based compensation | 130.62 Thousand | 229.5 Thousand | 426.26 Thousand | 505.67 Thousand | 190.75 Thousand | - |
Change in working capital | 637.33 Thousand | -364.87 Thousand | 76.09 Thousand | -5760.51 | -2310.61 | -85.79 Thousand |
Other non-cash items | -554.93 Thousand | 1.55 Million | 1.08 Million | 379.12 Thousand | 386.05 Thousand | 95.13 Thousand |
Investing Cash Flow | -844.35 Thousand | -1.4 Million | -2.93 Million | -1.24 Million | -418.13 Thousand | -790.17 Thousand |
Investments in PPE | -554.14 Thousand | -1.4 Million | -2.93 Million | -1.24 Million | -418.13 Thousand | -591.09 Thousand |
Acquisitions | -290.2 Thousand | - | - | - | - | - |
Investment purchases | - | - | - | - | - | -199.07 Thousand |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | -554.14 Thousand | -2.1 Million | - | - | - | -1.00 |
Financing Cash Flow | 2.39 Million | 1.53 Million | 1.62 Million | 6.11 Million | 721.49 Thousand | 1.05 Million |
Debt repayment | - | - | - | -7573.57 | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | -164.62 Thousand | - | - | -51.49 Thousand | -7257.00 | -100.28 Thousand |
Common Stock Issuance | 2.56 Million | 1.53 Million | 1.62 Million | 6.12 Million | 721.49 Thousand | 1.05 Million |
Other Financing Activities | 2.39 Million | 2299.29 | 2361.98 | 51.49 Thousand | 7257.00 | 100.28 Thousand |
Accounts receivables | 8438.00 | -413.93 Thousand | -108.84 Thousand | 5884.38 | -8516.07 | 8255.38 |
Accounts payables | - | 51.79 Thousand | 174.06 Thousand | -25.84 Thousand | 30.06 Thousand | -91.49 Thousand |
Inventory | - | -0.07 | -1.00 | 0.11 | 0.46 | -0.29 |
Other working capital | 628.89 Thousand | -2735.93 | 10.86 Thousand | 14.2 Thousand | -23.85 Thousand | -2562.09 |
Cash at beginning of period | 1.79 Million | 2.38 Million | 4.87 Million | 622.6 Thousand | 838.76 Thousand | 1.4 Million |
Cash at end of period | 1.97 Million | 1.19 Million | 2.38 Million | 4.87 Million | 622.6 Thousand | 838.76 Thousand |
Capital Expenditure | -554.14 Thousand | -1.4 Million | -2.93 Million | -1.24 Million | -418.13 Thousand | -591.09 Thousand |
Effect of forex changes on cash | - | -83.17 Thousand | -394.72 Thousand | 56.29 Thousand | -15.83 Thousand | -70.42 Thousand |
Net cash flow / Change in cash | 176.3 Thousand | -1.19 Million | -2.49 Million | 4.25 Million | -216.16 Thousand | -563.58 Thousand |
Free Cash Flow | -1.93 Million | -2.63 Million | -3.72 Million | -1.91 Million | -921.81 Thousand | -1.35 Million |
Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -1.07 Million | -1.95 Million | -2.42 Million | -486.72 Thousand | -1.95 Million | -1.32 Million |
Depreciation & Amortization | - | - | 2109.16 | - | 1147.58 | - |
Deferred income taxes | - | - | -2338.66 | - | -1573.83 | - |
Stock-based compensation | - | - | 229.5 Thousand | - | 426.26 Thousand | - |
Change in working capital | - | - | -364.87 Thousand | - | 76.09 Thousand | - |
Other non-cash items | 465.04 Thousand | 1.17 Million | 1.55 Million | 22.63 Thousand | 1.08 Million | 955.91 Thousand |
Investing Cash Flow | -400.36 Thousand | 36.33 Thousand | -1.4 Million | -1.47 Million | -2.93 Million | -1.72 Million |
Investments in PPE | -220.75 Thousand | 36.33 Thousand | -1.4 Million | -1.47 Million | -2.93 Million | -1.72 Million |
Acquisitions | -179.6 Thousand | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | -1.00 | - | - | - | - | - |
Financing Cash Flow | 392.97 Thousand | 955.67 Thousand | 1.53 Million | 588.96 Thousand | 1.62 Million | 1.62 Million |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | 392.97 Thousand | 955.67 Thousand | 1.53 Million | 588.96 Thousand | 1.62 Million | 1.62 Million |
Other Financing Activities | - | - | 2299.29 | - | 2361.98 | - |
Accounts receivables | - | - | -413.93 Thousand | - | -108.84 Thousand | - |
Accounts payables | - | - | 51.79 Thousand | - | 174.06 Thousand | - |
Inventory | - | - | -0.07 | - | -1.00 | - |
Other working capital | - | - | -2735.93 | - | 10.86 Thousand | - |
Cash at beginning of period | 1.19 Million | 1.01 Million | 2.38 Million | 2.38 Million | 4.87 Million | 3 Million |
Cash at end of period | 602.13 Thousand | 1.19 Million | 1.19 Million | 1.01 Million | 2.38 Million | 2.38 Million |
Capital Expenditure | -220.75 Thousand | 36.33 Thousand | -1.4 Million | -1.47 Million | -2.93 Million | -1.72 Million |
Effect of forex changes on cash | 26.57 Thousand | -22.83 Thousand | -83.17 Thousand | -29.88 Thousand | -394.72 Thousand | -146.61 Thousand |
Net cash flow / Change in cash | -595.32 Thousand | 186.33 Thousand | -1.19 Million | -1.37 Million | -2.49 Million | -611.62 Thousand |
Free Cash Flow | -835.26 Thousand | -746.5 Thousand | -2.63 Million | -1.93 Million | -3.72 Million | -2.09 Million |
VIVOBIOT
9644
4114
EWRC
AGYS
PNC